Diplomat Pharmacy (DPLO) PT Cut to $14 at Cowen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. IVBIY
9. SPY
10. FIX

Go back to Diplomat Pharmacy (DPLO) PT Cut to $14 at Cowen

Diplomat Pharmacy (DPLO) Sees FY16 Adj. EBITDA Near Low End of Previous Ranges; to Acquire Affinity

January 9, 2017 6:30 AM EST

Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced updated 2016 financial guidance. The company now expects 2016 revenue and adjusted EBITDA will be at or near the low end of previously announced ranges.

Phil Hagerman, chairman and CEO of Diplomat, commented, "This was a tough year for Diplomat, and as a result of the various industry challenges we faced throughout 2016, we anticipate our full-year financial results to be at or near the low end of our previous expectations. Looking forward, overall industry challenges, continued competition, and weaker than expected FDA approvals... More